| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771 |
| filingDate |
2017-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a77a51567eb3c02b665bc1fa7312479c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_365dc620e1be540d7f69501fe09c91ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb3ff7b477cdce1ab619ec5535ff2c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad0fa55d1771fa32dfb2b79112015ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fe6d07bd9ab40f0615be942f6e2f44a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3428d856d58585700efe1fa7307f70d9 |
| publicationDate |
2021-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-038580-B1 |
| titleOfInvention |
FXR AGONIST, STEROID DERIVATIVE |
| abstract |
The invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof and relates to the routes of their use for the preparation of medicaments for the treatment of diseases associated with FXR |
| priorityDate |
2016-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |